Dual Antiplatelet Therapy Duration in Conservatively Managed Patients with Acute Coronary Syndrome: Any News?

Am J Med. 2017 Nov;130(11):e515. doi: 10.1016/j.amjmed.2017.06.035.

Authors

Paolo Calabrò¹, Felice Gragnano¹, Leonardo De Luca²

Affiliations

¹ Division of Cardiology, Department of Cardiothoracic and Respiratory Sciences, University of Campania "Luigi Vanvitelli", A.O. dei Colli Monaldi Hospital, L. Bianchi 1,Naples 80131, Italy.
² Division of Cardiology, Laboratory of Interventional Cardiology, San Giovanni Evangelista Hospital, Via Parrozzani 3,Tivoli, Rome 00019, Italy.

PMID: 29073976
DOI: 10.1016/j.amjmed.2017.06.035

No abstract available

Publication types

Letter
Comment

MeSH terms

Acute Coronary Syndrome*
Aspirin
Drug Therapy, Combination
Humans
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors*
Ticlopidine

Substances

Platelet Aggregation Inhibitors
Ticlopidine
Aspirin